These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7773644

  • 1. Pathogenesis, experimental manipulation and treatment of liver fibrosis.
    Arthur MJ.
    Exp Nephrol; 1995; 3(2):90-5. PubMed ID: 7773644
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis.
    Baroni GS, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A.
    Hepatology; 1996 May; 23(5):1189-99. PubMed ID: 8621153
    [Abstract] [Full Text] [Related]

  • 5. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC, Chung JJ.
    J Investig Med; 1994 Dec; 42(4):660-70. PubMed ID: 8521029
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [Abstract] [Full Text] [Related]

  • 7. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.
    Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ.
    Gastroenterology; 1996 Mar; 110(3):821-31. PubMed ID: 8608892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-beta 1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat.
    Krull NB, Zimmermann T, Gressner AM.
    Hepatology; 1993 Sep; 18(3):581-9. PubMed ID: 8359799
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
    Camino AM, Atorrasagasti C, Maccio D, Prada F, Salvatierra E, Rizzo M, Alaniz L, Aquino JB, Podhajcer OL, Silva M, Mazzolini G.
    J Gene Med; 2008 Sep; 10(9):993-1004. PubMed ID: 18615449
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of the catabolic effects of interleukin-1 beta on human articular chondrocytes by transforming growth factor-beta.
    Lum ZP, Hakala BE, Mort JS, Recklies AD.
    J Cell Physiol; 1996 Feb; 166(2):351-9. PubMed ID: 8591995
    [Abstract] [Full Text] [Related]

  • 20. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
    Arthur MJ, Mann DA, Iredale JP.
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.